GLP-1 Receptor Agonist
  1. Home
  2. Rybelsus
  3. GLP-1 Receptor Agonist

GLP-1 Receptor Agonist

GLP-1 Receptor Agonist is a class of prescription medicines used to improve glycemic control in adults with type 2 diabetes and, for certain products, to support chronic weight management. These medications are available in oral tablets and subcutaneous injection formulations. They help provide effective long-term metabolic management when used alongside diet and exercise.

BUY NOW

Category

GLP-1 Receptor Agonists mimic the action of the naturally occurring glucagon-like peptide-1 hormone by stimulating glucose-dependent insulin secretion, suppressing glucagon release, slowing gastric emptying, and increasing satiety. They are widely used in the management of type 2 diabetes and selected weight management programs due to their proven efficacy and convenient dosing options. Manufactured under stringent pharmaceutical quality standards, GLP-1 receptor agonists are available in oral tablets, prefilled injection pens, and multi-dose delivery systems. These medicines should be used only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name GLP-1 Receptor Agonist
Therapeutic Class Glucagon-Like Peptide-1 Receptor Agonist
Dosage Forms Oral Tablets, Prefilled Injection Pens
Route of Administration Oral / Subcutaneous Injection
Indications Type 2 Diabetes Mellitus, Chronic Weight Management (Product Dependent)
Storage As Per Product Label

Product Also Known As

GLP-1 Receptor Agonist, GLP-1 Agonist, Glucagon-Like Peptide-1 Agonist, GLP-1 Diabetes Medicine, GLP-1 Weight Management Therapy, Incretin-Based Therapy, GLP-1 Medication